These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10084638)

  • 1. Olanzapine response in psychotic depression.
    Rothschild AJ; Bates KS; Boehringer KL; Syed A
    J Clin Psychiatry; 1999 Feb; 60(2):116-8. PubMed ID: 10084638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of acute response with olanzapine in psychotic mood disorders.
    Zarate CA; Narendran R; Tohen M; Greaney JJ; Berman A; Pike S; Madrid A
    J Clin Psychiatry; 1998 Jan; 59(1):24-8. PubMed ID: 9491062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does olanzapine have antidepressant properties? A retrospective preliminary study.
    Ghaemi SN; Cherry EL; Katzow JA; Goodwin FK
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):196-9. PubMed ID: 11256687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
    Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
    J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of olanzapine in non-psychotic psychiatric disorders.
    Goodnick PJ; Barrios CA
    Expert Opin Pharmacother; 2001 Apr; 2(4):667-80. PubMed ID: 11336615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar I disorder in an adolescent with olanzapine.
    Khouzam HR; El-Gabalawi F
    J Child Adolesc Psychopharmacol; 2000; 10(2):147-51. PubMed ID: 10933124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open trial of olanzapine in the treatment of patients with psychotic depression.
    Nelson EB; Rielage E; Welge JA; Keck PE
    Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD; Sanger TM; Lu Y; Thieme ME
    Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
    Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
    Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():41-5. PubMed ID: 9766619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to managing psychotic depression.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 1():19-23. PubMed ID: 12625801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturalistic study of olanzapine in treatment-resistant schizophrenia and acute mania, depression and obsessional disorder.
    Ohaeri JU
    East Afr Med J; 2000 Feb; 77(2):86-92. PubMed ID: 10774081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.